| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 1126 |
| 1 | OLANZAPINE | 173 |
| 2 | PREDNISONE | 166 |
| 3 | ALBUTEROL SULFATE | 149 |
| 4 | LANSOPRAZOLE | 125 |
| 5 | ALBUTEROL | 109 |
| 6 | ARIPIPRAZOLE | 107 |
| 7 | ARIPIPRAZOLE ORAL | 100 |
| 8 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 100 |
| 9 | LORAZEPAM | 91 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EDETATE CALCIUM DISODIUM | 29 | 0.7250 |
| 1 | AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE | 10 | 0.0855 |
| 2 | 5-HYDROXYTRYPTOPHAN | 1 | 0.0189 |
| 3 | ISATUXIMAB-IRFC | 1 | 0.0185 |
| 4 | AMISULPRIDE | 85 | 0.0139 |
| 5 | CLOZAPINE | 1126 | 0.0089 |
| 6 | SODIUM HYALURONATE | 6 | 0.0073 |
| 7 | DIFLORASONE DIACETATE | 1 | 0.0052 |
| 8 | DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE | 2 | 0.0046 |
| 9 | OMEPRAZOLE MAGNESIUM, AMOXICILLIN AND RIFABUTIN | 1 | 0.0046 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 1153 |
| 1 | Corticosteroid [EPC] | 329 |
| 2 | Benzodiazepine [EPC] | 203 |
| 3 | Proton Pump Inhibitor [EPC] | 198 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 176 |
| 5 | Interleukin-5 Antagonist [EPC] | 115 |
| 6 | Mood Stabilizer [EPC] | 104 |
| 7 | Vitamin C [EPC] | 101 |
| 8 | Vitamin B12 [EPC] | 96 |
| 9 | Anti-epileptic Agent [EPC] | 95 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 115 | 0.1672 |
| 1 | Dopamine-2 Receptor Antagonist [EPC] | 85 | 0.0109 |
| 2 | Provitamin D2 Compound [EPC] | 92 | 0.0031 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 24 | 0.0028 |
| 4 | Atypical Antipsychotic [EPC] | 1153 | 0.0026 |
| 5 | Osmotic Diuretic [EPC] | 13 | 0.0025 |
| 6 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 47 | 0.0022 |
| 7 | Typical Antipsychotic [EPC] | 40 | 0.0016 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 30 | 0.0015 |
| 9 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |